These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 179911

  • 1. Utilization of the quantitative assay of lipoprotein X in the differential diagnosis of extraphepatic obstructive jaundice and intrahepatic diseases.
    Magnani HN, Alaupovic P.
    Gastroenterology; 1976 Jul; 71(1):87-93. PubMed ID: 179911
    [Abstract] [Full Text] [Related]

  • 2. [Abnormal lipoprotein (LP-X) in the first months of life with particular reference to obstructive jaundice (author's transl)].
    Lachmann D.
    Wien Klin Wochenschr Suppl; 1977 Jul; 69():3-28. PubMed ID: 266315
    [Abstract] [Full Text] [Related]

  • 3. LP-X in cholestasis.
    Tanno H, Fay O, Palazzi J, Pedrana R, Yäger E, Roncoroni M.
    Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):289-91. PubMed ID: 173123
    [Abstract] [Full Text] [Related]

  • 4. Lipoprotein-X levels in extrahepatic versus intrahepatic cholestasis.
    Simon JB, Poon RW.
    Gastroenterology; 1978 Aug; 75(2):177-80. PubMed ID: 208914
    [Abstract] [Full Text] [Related]

  • 5. [Lipoprotein X in hepatobiliary diseases].
    Mordasini RC, Berthold S, Schlumpf E, Keller H, Riva G.
    Schweiz Med Wochenschr; 1975 Jul 05; 105(27):863-72. PubMed ID: 2969
    [Abstract] [Full Text] [Related]

  • 6. [The significance of lipoprotein X in the diagnosis of obstructive jaundice: comparison with other biochemical tests (author's transl)].
    Mayr K.
    Dtsch Med Wochenschr; 1975 Oct 24; 100(43):2193-7. PubMed ID: 240665
    [Abstract] [Full Text] [Related]

  • 7. On the occurrence of lipoprotein-x in non-hemolytic jaundice.
    Samsioe G, Lundborg H, Ivarsson S, Gustafson A.
    Acta Chir Scand; 1976 Oct 24; 142(3):187-90. PubMed ID: 180734
    [Abstract] [Full Text] [Related]

  • 8. Lipoprotein-X in patients with cirrhosis: its relationship to cholestasis and hypercholesterolemia.
    Sörös P, Böttcher J, Maschek H, Selberg O, Müller MJ.
    Hepatology; 1998 Nov 24; 28(5):1199-205. PubMed ID: 9794902
    [Abstract] [Full Text] [Related]

  • 9. Quantitative determination of the abnormal lipoprotein of cholestasis, LP-X, in liver disease.
    Ritland S.
    Scand J Gastroenterol; 1975 Nov 24; 10(1):5-15. PubMed ID: 164686
    [Abstract] [Full Text] [Related]

  • 10. [Lipoprotein X (LP-X) in the differential diagnosis of cholestasis in children, with special reference to biliary atresia].
    Duchnowska A, Wach K, Poradowska W.
    Probl Med Wieku Rozwoj; 1979 Nov 24; 8():84-91. PubMed ID: 263531
    [Abstract] [Full Text] [Related]

  • 11. Lipoprotein-X and other tests in the diagnosis of obstructive jaundice in the infant.
    Lipsitz PJ, Yoss B, Schussheim A.
    Am J Gastroenterol; 1979 Jan 24; 71(1):95-100. PubMed ID: 86296
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic importance of lipoprotein-X (LP-X) in the diagnosis of cholestasis.
    Palynyczko Z, Milewski B.
    Mater Med Pol; 1975 Jan 24; 7(4):327-33. PubMed ID: 175222
    [Abstract] [Full Text] [Related]

  • 13. Quantitative changes of serum lipoprotein-X after cholestyramine administration in infants with cholestatic biliary tract and liver disease.
    Poley JR, Caplan DB, Magnani HN, Alaupovic P, Smith EI, Campbell DP, Bhatia M, Burdelski M, Bojanovski D.
    Eur J Clin Invest; 1978 Dec 24; 8(6):397-404. PubMed ID: 105912
    [Abstract] [Full Text] [Related]

  • 14. Significance of serum lipoproteid-X (LP-X) determination for the diagnosis of cholestasis in chronic liver diseases.
    Milewski B, Palynyczko Z.
    Pol Med Sci Hist Bull (1973); 1975 Dec 24; 15(5-6):551-5. PubMed ID: 1228704
    [Abstract] [Full Text] [Related]

  • 15. Lipoprotein abnormalities in cholestasis. I. Electrophoretic and ultracentrifugal analyses.
    Watanabe M.
    Acta Med Okayama; 1979 Aug 24; 33(4):269-85. PubMed ID: 227230
    [Abstract] [Full Text] [Related]

  • 16. [LP-X in the first month of life (author's transl)].
    Lachmann D, Eder G.
    Padiatr Padol; 1977 Aug 24; 12(4):334-8. PubMed ID: 904943
    [Abstract] [Full Text] [Related]

  • 17. Plasma concentration of lipoprotein-X (LP-X) in experimental bile duct obstruction.
    Ritland S, Bergan A.
    Scand J Gastroenterol; 1975 Aug 24; 10(1):17-24. PubMed ID: 1124340
    [Abstract] [Full Text] [Related]

  • 18. Contrasting liver function test patterns in obstructive jaundice due to biliary strictures [corrected] and stones.
    Hayat JO, Loew CJ, Asrress KN, McIntyre AS, Gorard DA.
    QJM; 2005 Jan 24; 98(1):35-40. PubMed ID: 15625352
    [Abstract] [Full Text] [Related]

  • 19. Lipoprotein-X (LP-X) in liver disease.
    Ritland S, Blomhoff JP, Elgjo K, Gjone E.
    Scand J Gastroenterol; 1973 Jan 24; 8(2):155-60. PubMed ID: 4697077
    [No Abstract] [Full Text] [Related]

  • 20. [LP-X in newborns: increased incidence of positive tests without cholestasis (author's transl)].
    Witt I, Ober M.
    J Clin Chem Clin Biochem; 1976 Apr 24; 14(4):197-202. PubMed ID: 5573
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.